We are live on ! Find out more
ANIK icon

Anika Therapeutics
ANIK

160 hedge funds and large institutions have $483M invested in Anika Therapeutics in 2014 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 56 increasing their positions, 57 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 15

19% more capital invested

Capital invested by funds: $405M → $483M (+$77.5M)

5% more funds holding

Funds holding: 153 → 160 (+7)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

2% less repeat investments, than reductions

Existing positions increased: 56 | Existing positions reduced: 57

45% less call options, than puts

Call options by funds: $1.89M | Put options by funds: $3.46M

Holders
160
Holders Change
+7
Holders Change %
+4.58%
% of All Funds
4.27%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
25
Increased
56
Reduced
57
Closed
15
Calls
$1.89M
Puts
$3.46M
Net Calls
-$1.56M
Net Calls Change
-$368K

Top Buyers

1
RIM
Ranger Investment Management
Texas
+$15.4M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$12.6M
3
BTW
Boston Trust Walden
Massachusetts
+$12.3M
4
LCP
Lombardia Capital Partners
California
+$5.5M
5
BFA
BlackRock Fund Advisors
California
+$2.93M

Top Sellers

1
Millennium Management
Millennium Management
New York
-$8.04M
2
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$5.7M
3
Morgan Stanley
Morgan Stanley
New York
-$4.66M
4
NI
Numeric Investors
Massachusetts
-$3.26M
5
TC
TFS Capital
Pennsylvania
-$2.38M
Name Holding Trade Value Shares
Change 		Change in
Stake
Teacher Retirement System of Texas
151
Teacher Retirement System of Texas
Texas
$17K -$3.48K -89 -17%
BlackRock
152
BlackRock
New York
$13K – – –
TRCT
153
Tower Research Capital (TRC)
New York
$13K +$10.4K +265 +457%
MA
154
MCF Advisors
Kentucky
$10K – – –
SIA
155
Stancorp Investment Advisers
Oregon
$4K +$3.52K +90 New
BC
156
Bartlett & Co
Ohio
$3K +$3.13K +80 New
GC
157
Globeflex Capital
California
$1K -$195 -5 -14%
GAM
158
Gemmer Asset Management
California
$1K +$508 +13 +118%
Manulife (Manufacturers Life Insurance)
159
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$375 -$12.3K -315 -3%
BRWA
160
B. Riley Wealth Advisors
Florida
$1 +$1.17K +30 New
NI
161
Numeric Investors
Massachusetts
– -$3.26M -88,972 Closed
TC
162
TFS Capital
Pennsylvania
– -$2.38M -64,896 Closed
HHC
163
Hutchin Hill Capital
New York
– -$1.7M -46,400 Closed
Jane Street
164
Jane Street
New York
– -$906K -24,724 Closed
Arrowstreet Capital
165
Arrowstreet Capital
Massachusetts
– -$632K -17,236 Closed
OAM
166
Oberweis Asset Management
Illinois
– -$566K -15,450 Closed
EMG
167
Ellington Management Group
Connecticut
– -$348K -9,500 Closed
Commonwealth Equity Services
168
Commonwealth Equity Services
Massachusetts
– -$343K -9,350 Closed
VKH
169
Virtu KCG Holdings
New York
– -$249K -6,797 Closed
Two Sigma Investments
170
Two Sigma Investments
New York
– -$249K -6,795 Closed
BPGAM
171
BTG Pactual Global Asset Management
Bermuda
– -$244K -6,654 Closed
ProShare Advisors
172
ProShare Advisors
Maryland
– -$224K -6,097 Closed
KBC Group
173
KBC Group
Belgium
– -$141K -3,841 Closed
BNP Paribas Financial Markets
174
BNP Paribas Financial Markets
France
– -$39.2K -1,070 Closed
RIA
175
Regal Investment Advisors
Michigan
– -$21K -578 Closed
3 4 5 6
7

ANIK Hedge Fund Activity: Q4 2014 in Review

160 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Anika Therapeutics (ANIK) for Q4 2014, worth a combined $483M — up 19% from $405M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new ANIK positions and 15 closed out — a net gain of 10 holders — while 56 added to existing stakes and 57 trimmed.

The largest buyer was Ranger Investment Management, adding an estimated $15.4M. The largest seller was Millennium Management, cutting an estimated $8.04M.

  • 160 institutional investors held Anika Therapeutics (ANIK) as of Q4 2014, up from 153 in Q3 2014.
  • Funds reported $483M of Anika Therapeutics stock for Q4 2014, up 19% quarter-over-quarter.
  • 25 funds opened new Anika Therapeutics positions in Q4 2014 and 15 closed out, a net change of +10 holders.
  • The largest Anika Therapeutics buyer in Q4 2014 was Ranger Investment Management, an estimated $15.4M added.
  • The largest Anika Therapeutics seller in Q4 2014 was Millennium Management, an estimated $8.04M sold.

Based on aggregated 13F filings for Q4 2014.